189 related articles for article (PubMed ID: 29668803)
21. Medicinal and poisonous diversity of the flora of "Cariri Paraibano", Brazil.
Agra MF; Baracho GS; Nurit K; Basílio IJ; Coelho VP
J Ethnopharmacol; 2007 May; 111(2):383-95. PubMed ID: 17236731
[TBL] [Abstract][Full Text] [Related]
22. "Studies on biodiversity of Vietnam and Laos" 1998-2005: examining the impact.
Soejarto DD; Zhang HJ; Fong HH; Tan GT; Ma CY; Gyllenhaal C; Riley MC; Kadushin MR; Franzblau SG; Bich TQ; Cuong NM; Hiep NT; Loc PK; Xuan le T; Hai NV; Hung NV; Chien NQ; Binh le T; Vu BM; Ly HM; Southavong B; Sydara K; Bouamanivong S; Pezzuto JM; Rose WC; Dietzman GR; Miller BE; Thuy TV
J Nat Prod; 2006 Mar; 69(3):473-81. PubMed ID: 16562860
[TBL] [Abstract][Full Text] [Related]
23. A perspective on natural products research and ethnopharmacology in Mexico: the eagle and the serpent on the prickly pear cactus.
Heinrich M; Frei Haller B; Leonti M
J Nat Prod; 2014 Mar; 77(3):678-89. PubMed ID: 24559070
[TBL] [Abstract][Full Text] [Related]
24. The bioeconomy in Italy and the new national strategy for a more competitive and sustainable country.
Fava F; Gardossi L; Brigidi P; Morone P; Carosi DAR; Lenzi A
N Biotechnol; 2021 Mar; 61():124-136. PubMed ID: 33220517
[TBL] [Abstract][Full Text] [Related]
25. [Opportunities in the pharmaceutical industry and the local development logic based on the Brazilian biomes: the basis for a national policy discussion].
Villas Bôas Gde K; Gadelha CA
Cad Saude Publica; 2007 Jun; 23(6):1463-71. PubMed ID: 17546337
[TBL] [Abstract][Full Text] [Related]
26. The Laurencia Paradox: An Endless Source of Chemodiversity.
Harizani M; Ioannou E; Roussis V
Prog Chem Org Nat Prod; 2016; 102():91-252. PubMed ID: 27380407
[TBL] [Abstract][Full Text] [Related]
27. Brazilian Microbiome Project: revealing the unexplored microbial diversity--challenges and prospects.
Pylro VS; Roesch LF; Ortega JM; do Amaral AM; Tótola MR; Hirsch PR; Rosado AS; Góes-Neto A; da Costa da Silva AL; Rosa CA; Morais DK; Andreote FD; Duarte GF; de Melo IS; Seldin L; Lambais MR; Hungria M; Peixoto RS; Kruger RH; Tsai SM; Azevedo V;
Microb Ecol; 2014 Feb; 67(2):237-41. PubMed ID: 24173537
[TBL] [Abstract][Full Text] [Related]
28. Biodiversity as a source of anticancer drugs.
Tan G; Gyllenhaal C; Soejarto DD
Curr Drug Targets; 2006 Mar; 7(3):265-77. PubMed ID: 16515527
[TBL] [Abstract][Full Text] [Related]
29. Molluscan biological and chemical diversity: secondary metabolites and medicinal resources produced by marine molluscs.
Benkendorff K
Biol Rev Camb Philos Soc; 2010 Nov; 85(4):757-75. PubMed ID: 20105155
[TBL] [Abstract][Full Text] [Related]
30. Potential sources of biodynamically active natural products in Brazil.
Kaplan MA
Mem Inst Oswaldo Cruz; 1991; 86 Suppl 2():5-8. PubMed ID: 1668772
[TBL] [Abstract][Full Text] [Related]
31. Cheminformatic characterization of natural products from Panama.
Olmedo DA; González-Medina M; Gupta MP; Medina-Franco JL
Mol Divers; 2017 Nov; 21(4):779-789. PubMed ID: 28831697
[TBL] [Abstract][Full Text] [Related]
32. New Compounds and Potential Candidates for Drug Discovery from Medicinal Plants of Vietnam.
Giang PM; Otsuka H
Chem Pharm Bull (Tokyo); 2018; 66(5):493-505. PubMed ID: 29710046
[TBL] [Abstract][Full Text] [Related]
33. Thinking big about small beings--the (yet) underdeveloped microbial natural products chemistry in Brazil.
Ióca LP; Allard PM; Berlinck RG
Nat Prod Rep; 2014 May; 31(5):646-75. PubMed ID: 24691682
[TBL] [Abstract][Full Text] [Related]
34. New Caledonia: A ' Hot Spot' for Valuable Chemodiversity: Part 2: Basal Angiosperms and Eudicot Rosids.
Coulerie P; Poullain C
Chem Biodivers; 2016 Jan; 13(1):18-36. PubMed ID: 26765350
[TBL] [Abstract][Full Text] [Related]
35. Paving New Roads Towards Biodiversity-Based Drug Development in Brazil: Lessons from the Past and Future Perspectives.
Braga FC
Rev Bras Farmacogn; 2021; 31(5):505-518. PubMed ID: 34548709
[TBL] [Abstract][Full Text] [Related]
36. Brazil needs a national debate on bioprospecting.
Zani CL
An Acad Bras Cienc; 1999; 71(2):289-93. PubMed ID: 10412496
[TBL] [Abstract][Full Text] [Related]
37. Influence of Brazilian herbal regulations on the use and conservation of native medicinal plants.
Brandão MG; Cosenza GP; Stanislau AM; Fernandes GW
Environ Monit Assess; 2010 May; 164(1-4):369-77. PubMed ID: 19353281
[TBL] [Abstract][Full Text] [Related]
38. Ethnomedicinal survey of a maroon community in Brazil's Atlantic tropical forest.
de Santana BF; Voeks RA; Funch LS
J Ethnopharmacol; 2016 Apr; 181():37-49. PubMed ID: 26802786
[TBL] [Abstract][Full Text] [Related]
39. Exploring anti-TB leads from natural products library originated from marine microbes and medicinal plants.
Liu X; Chen C; He W; Huang P; Liu M; Wang Q; Guo H; Bolla K; Lu Y; Song F; Dai H; Liu M; Zhang L
Antonie Van Leeuwenhoek; 2012 Oct; 102(3):447-61. PubMed ID: 22814612
[TBL] [Abstract][Full Text] [Related]
40. Natural product drug discovery and development: new perspectives on international collaboration.
Baker JT; Borris RP; Carté B; Cordell GA; Soejarto DD; Cragg GM; Gupta MP; Iwu MM; Madulid DR; Tyler VE
J Nat Prod; 1995 Sep; 58(9):1325-57. PubMed ID: 7494142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
